ロード中...
A phase I trial of Proton stereotactic body radiation therapy for liver metastases
BACKGROUND: A phase I trial to determine the maximum tolerated dose (MTD) of Proton stereotactic body radiation therapy (SBRT) for liver metastases in anticipation of a subsequent phase II study. METHODS: An institutional IRB approved phase I clinical trial was conducted. Eligible patients had 1–3 l...
保存先:
| 出版年: | J Gastrointest Oncol |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AME Publishing Company
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6351312/ https://ncbi.nlm.nih.gov/pubmed/30788166 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2018.08.17 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|